O Brien Greene & Co. Inc Has $404,000 Position in Aflac Incorporated (NYSE:AFL)

O Brien Greene & Co. Inc lessened its stake in Aflac Incorporated (NYSE:AFL) by 4.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,525 shares of the financial services provider’s stock after selling 200 shares during the period. O Brien Greene & Co. Inc’s holdings in Aflac were worth $404,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Y.D. More Investments Ltd acquired a new stake in Aflac during the second quarter worth $25,000. Atwood & Palmer Inc. boosted its position in shares of Aflac by 80.0% during the 1st quarter. Atwood & Palmer Inc. now owns 315 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 140 shares in the last quarter. OFI Invest Asset Management bought a new stake in Aflac in the first quarter valued at about $29,000. Dixon Mitchell Investment Counsel Inc. acquired a new position in Aflac in the first quarter worth about $34,000. Finally, Sachetta LLC bought a new position in Aflac during the fourth quarter worth about $35,000. 67.44% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

AFL has been the subject of several analyst reports. Barclays began coverage on Aflac in a research report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 target price for the company. Piper Sandler lifted their price objective on Aflac from $95.00 to $100.00 and gave the company an “overweight” rating in a report on Friday, June 28th. JPMorgan Chase & Co. increased their target price on shares of Aflac from $80.00 to $83.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 2nd. Jefferies Financial Group decreased their price objective on shares of Aflac from $84.00 to $83.00 and set a “hold” rating on the stock in a research note on Friday, June 28th. Finally, UBS Group lifted their target price on shares of Aflac from $84.00 to $109.00 and gave the company a “neutral” rating in a research note on Wednesday, August 14th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $92.50.

Aflac Stock Down 0.6 %

Shares of AFL opened at $109.56 on Wednesday. The firm has a market capitalization of $62.25 billion, a price-to-earnings ratio of 12.09, a PEG ratio of 2.53 and a beta of 0.95. Aflac Incorporated has a 52 week low of $74.89 and a 52 week high of $111.14. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.10 and a current ratio of 0.10. The business’s fifty day moving average price is $101.89 and its two-hundred day moving average price is $91.45.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.60 by $0.23. The firm had revenue of $5.14 billion during the quarter, compared to analyst estimates of $4.10 billion. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The company’s revenue was down .7% on a year-over-year basis. During the same period last year, the company earned $1.58 earnings per share. On average, analysts predict that Aflac Incorporated will post 6.75 earnings per share for the current year.

Aflac Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 2nd. Investors of record on Wednesday, August 21st were issued a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $2.00 annualized dividend and a yield of 1.83%. Aflac’s dividend payout ratio is currently 22.08%.

Insider Buying and Selling at Aflac

In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of the company’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total transaction of $197,880.00. Following the completion of the sale, the director now owns 18,158 shares in the company, valued at approximately $1,796,552.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.90% of the company’s stock.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.